FDA Recommends Testing of Pharmaceutical Ingredients for Melamine

The U.S. FDA, in a guidance issued yesterday, says that certain pharmaceutical ingredients used in the manufacture or preparation of drug products should be tested for melamine. “Although the FDA has no reason to believe that the U.S. pharmaceutical supply is contaminated with melamine, recent events involving pet and livestock food products in the U.S., and milk products for infants in China, underscore the potential problem,” the agency says. The guidance is an initial measure by the agency in working with pharmaceutical manufacturers, repackers...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers